Results

Total Results: 918 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

41. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
    September 07, 2012 - The safety signal uncovered by the FDA was an excess of fetal death in patients exposed to 17P. … , of note each of these is mediated by the care provider as part of the process of care; none are patient … A it must work for patient B" clearly does not apply for 17OH. … Given that this document could be used to provide guidelines for patient care and change reimbursement … Physicians need to inform patients that there is a potential safety signal with the administration of

42. #06 Developmental Delays ADHD, and Autism (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
    January 01, 2012 - for the patient and caregiver. … caregiver, researcher, or clinician who is monitoring the readouts of those signals on a computer about indicators … safety.” 15 Several other experts were not as convinced about the intervention’s mechanism of action … The expert indicated the intervention may pose safety issues in patients with otitis media and asthma … Safety concerns, the closed environment of the HBOT chamber (which could cause claustrophobia), and

43. Patient-Centered-Medical-Home Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_executive.pdf
    July 01, 2012 - the variety of health care needs of patients and to improve patient and staff experiences, outcomes … A systems-based approach to improving quality and safety 3. … Coordination of care (as perceived by patients) c. Patient-provider interaction 2. … Effects on quality indicators for chronic illness care and on clinical outcomes are uncertain. … safety risks (e.g., patients using email for emergent medical issues), are possible and should be

44. Progestogens-Preterm-Birth Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
    September 01, 2012 - associated with preterm birth represent untold distress for families, as well as significant costs to patients … However, these groups also note interest in assessing long-term safety because the Effective Health … How do the effectiveness, adverse effects, and safety of progestogen treatment differ based on the maternal … How do the effectiveness, acceptability, adherence, adverse effects, and safety of progestogen treatment … One survey addressed patient demand; 63 percent reported that patients “never request”; 35 percent,

45. Medical Care Journal Supplement (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
    January 01, 2007 - The Comparative Effectiveness and Safety Emerging Methods Symposium: A Tribue to Harry A. … Methodologic Challenges to Studying Patient Safety and Comparative Effectiveness. … Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Developing Indicators of Inpatient Adverse Drug Events Through Non-Linear Analysis Using Administrative … Real-Time Vaccine Safety Surveillance for the Early Detection of Adverse Events.

46. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - statistical significance, unless they can state with certainty that the vaccine alone truly protects the patient … In addition, nothing is known about the patient factors which may influence the effect of the vaccine … 1 Research Gaps—Page 129 line 43 Please change to: “Large scale studies may help to determine patient … other AEs reported (regardless of whether they were pre-specified or mentioned spontaneously by the patient … Patients received either a single dose of Zostavax or placebo.

47. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
    December 01, 2011 - If a patient has responded to one agent in the past, is that agent better than current alternatives at … For adults with a depressive syndrome, do commonly used antidepressants differ in safety, adverse events … No evidence addressed how second-generation antidepressants compare when a patient responds to one agent … Furthermore, studies need to explore patient preferences about dosing regimens and the level of acceptance … Finally, no evidence addressed how second-generation antidepressants compare when a patient responds

48. Physiologic Predictors of Severe Injury: Systematic Review, Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-205-predictors-trauma-care-evidence-summary.pdf
    April 01, 2018 - and Quality in conjunction with the sponsoring partner agency, the National Highway Transportation Safety … If the indicators of high-risk patients were consistent, cleaner comparisons could be made both across … Washington, DC: National Highway Traffic Safety Administration; February 2013. … Prehospital triage in the injured pediatric patient. … Decision tool for the early diagnosis of trauma patient hypovolemia.

49. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
    April 06, 2010 - Timing We will include studies if patients have been on the medications for at least 3 months. … control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients … Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis … Inclusion and exclusion criteria Population and condition of interest □ All studies included patients … We excluded studies that evaluated only patients with type I diabetes, impaired glucose tolerance, metabolic

50. S5 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - Lohr, PhD Background: Interest in new methods for comparative effective- ness, drug and patient safety … Key Words: comparative effectiveness, drug safety, health care, methods, patient safety, pharmaceuticals … For decades, researchers have used Medicaid data for research on the initiation, continuation, and patient … Methodologic challenges to studying patient safety and comparative effectiveness. … Developing indicators of inpatient adverse drug events through nonlinear analysis using admin- istrative

51. Refining Key Questions: Interactive Case Study Quiz
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical

52. Refining Key Questions: Interactive Case Study Quiz
    effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical

53. The Role of Immunotherapy and the Management of Asthma: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
    September 14, 2016 - While the severity of disease varies between patients and over time in the same patient, asthma can … there is clear evidence of a relationship between symptoms and exposure to an allergen to which the patient … use of medications.32 However, many studies may not define clearly the population or characterize indicators … The activity domain contains 5 ‘patient-specific’ questions. … c) Serious adverse events (SAE): The event is serious and should be reported when the patient outcome

54. Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
    February 01, 2024 - What patient safety measures or indicators have been used to examine the harm associated with polypharmacy … We answered Review Questions 1 and 2 by focusing on the harms and patient safety measures or indicators … safety measures, AHRQ’s Patient Safety Indicators, or the National Committee for Quality Assurance … patient safety–related measures. … What Patient Safety Measures or Indicators Have Been Used To Examine the Harm Associated With Polypharmacy

55. Updating Current Effectiveness Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
    September 15, 2008 - In doing so, CERs more closely parallel the decisions facing clinicians, patients and policymakers, … • Has there been a change in scope (e.g., new patient populations, new outcomes)? … Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer … of medical, surgical, and endoscopic treatments for improving objective and subjective outcomes in patients … Yes/No Yes/No Yes/No 7 10 percent to 65 percent of surgical patients still require medications

56. #05 DEPRESSION (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Preliminary data for these interventions are promising, and ongoing trials are clarifying the safety … Results and Discussion of Comments Seven experts, with clinical, research, patient safety, and health … widespread, if data support its efficacy and safety, the experts thought. … Investigators reported high patient adherence (81% and 94%; adherence defined as patients completing … that SPARX could positively affect patient health outcomes by providing an alternative for patients

57. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - What patient safety measures or indicators have been used to examine the harm associated with anticoagulant … safety measures or indicators. … Contextual information • Rationale for PSPs • Patient safety measures or indicators • Toolkits and … What Patient Safety Measures or Indicators Have Been Used To Examine the Harm Associated With Anticoagulant … Director, General Patient Safety Program Center for Quality Improvement and Patient Safety Agency for

58. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
    January 01, 2013 - with the underlying disease and its severity, general health status or frailty, quality of life, and patient … factor for adverse metabolic outcomes, but the magnitude of the confounding depends on the metabolic safety … Multiple data sources can be linked to enhance the validity of observational comparative effectiveness and safety … A direct relationship between the level of physician experience and better patient outcomes has been … A relationship between larger hospital volume and favorable patient outcomes is also well documented.

59. White Paper: Enhancing Systematic Review Methods by Incorporating Unpublished Drug Trials (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
    December 01, 2024 - The information in this report is intended to help healthcare decision makers—patients and clinicians … information, i.e., in the context of available resources and circumstances presented by individual patients … Most AHRQ documents are publicly available to use for noncommercial purposes (research, clinical or patient … Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo- controlled study … Efficacy and safety of mifepristone in the treatment of male US veterans with posttraumatic stress

60. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
    March 13, 2012 - The FDA addresses the safety and effectiveness of diagnostic tests and the quality of the design and … Historically, the FDA has subjected test kits to premarket review of safety and effectiveness but not … Clinical utility should reflect patient outcomes such as improved survival. … result from both preanalytic factors [e.g., sample preparation] as well as analytic factors [such as reagents … Patient advocacy Web sites for colon cancer will be searched.